<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37394847</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0578-1426</ISSN><JournalIssue CitedMedium="Print"><Volume>62</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Zhonghua nei ke za zhi</Title><ISOAbbreviation>Zhonghua Nei Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Recommendations for diagnosis and treatment of systemic lupus erythematosus].</ArticleTitle><Pagination><StartPage>775</StartPage><EndPage>784</EndPage><MedlinePgn>775-784</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112138-20221027-00793</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with complicated pathogenesis and diverse clinical manifestations. The current recommendations of the Chinese Rheumatology Association are based on a comprehensive investigation of evidence based medicine, domestic and international guidelines for SLE, and experts' proposals, and aim to provide a more scientific and authoritative reference for the diagnosis and management of SLE. The recommendations focus on four aspects; clinical manifestations, laboratory evaluation, diagnosis and disease assessment, and disease treatment and monitoring. The goal of the recommendations is to standardize the diagnosis and treatment of SLE in China so as to improve the prognosis of SLE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai 200001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>L H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>L J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Qilu Hospital of Shandong University, Jinan 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>X F</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Nei Ke Za Zhi</MedlineTA><NlmUniqueID>16210490R</NlmUniqueID><ISSNLinking>0578-1426</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="Y">Rheumatology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#xff08;SLE&#xff09;&#x662f;&#x4e00;&#x79cd;&#x7cfb;&#x7edf;&#x6027;&#x81ea;&#x8eab;&#x514d;&#x75ab;&#x75c5;&#xff0c;&#x5176;&#x53d1;&#x75c5;&#x673a;&#x5236;&#x590d;&#x6742;&#x3001;&#x4e34;&#x5e8a;&#x8868;&#x73b0;&#x591a;&#x6837;&#x3002;&#x4e3a;SLE&#x7684;&#x8bca;&#x7597;&#x63d0;&#x4f9b;&#x66f4;&#x4e3a;&#x79d1;&#x5b66;&#x3001;&#x6743;&#x5a01;&#x7684;&#x53c2;&#x8003;&#x4f9d;&#x636e;&#xff0c;&#x4e2d;&#x534e;&#x533b;&#x5b66;&#x4f1a;&#x98ce;&#x6e7f;&#x75c5;&#x5b66;&#x5206;&#x4f1a;&#x5728;&#x5145;&#x5206;&#x53c2;&#x8003;&#x5404;&#x7ea7;&#x5faa;&#x8bc1;&#x533b;&#x5b66;&#x8bc1;&#x636e;&#x3001;&#x56fd;&#x5185;&#x5916;&#x6743;&#x5a01;&#x8bca;&#x6cbb;&#x6307;&#x5357;&#x548c;&#x4e13;&#x5bb6;&#x5efa;&#x8bae;&#x7684;&#x57fa;&#x7840;&#x4e0a;&#xff0c;&#x5236;&#x5b9a;&#x4e86;&#x672c;&#x89c4;&#x8303;&#xff0c;&#x4ece;&#x4e34;&#x5e8a;&#x8868;&#x73b0;&#x3001;&#x8f85;&#x52a9;&#x68c0;&#x67e5;&#x3001;&#x8bca;&#x65ad;&#x4e0e;&#x8bc4;&#x4f30;&#x3001;&#x6cbb;&#x7597;&#x4e0e;&#x76d1;&#x6d4b;&#x56db;&#x4e2a;&#x65b9;&#x9762;&#x5bf9;SLE&#x7684;&#x89c4;&#x8303;&#x5316;&#x8bca;&#x6cbb;&#x8fdb;&#x884c;&#x8be6;&#x7ec6;&#x9610;&#x8ff0;&#xff0c;&#x65e8;&#x5728;&#x63d0;&#x9ad8;&#x5e7f;&#x5927;&#x98ce;&#x6e7f;&#x514d;&#x75ab;&#x79d1;&#x533b;&#x751f;&#x8bca;&#x6cbb;SLE&#x7684;&#x79d1;&#x5b66;&#x6027;&#x548c;&#x89c4;&#x8303;&#x6027;&#xff0c;&#x6539;&#x5584;&#x60a3;&#x8005;&#x9884;&#x540e;&#x3002;.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37394847</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112138-20221027-00793</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>